Abstract
The recent spate of high-profile genome-wide association studies identifying genetic variants linked with common complex diseases have confirmed the power of the approach, but what next? Dan Jones investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Scanning for success. Nat Rev Drug Discov 6, 590–591 (2007). https://doi.org/10.1038/nrd2393
Issue Date:
DOI: https://doi.org/10.1038/nrd2393
This article is cited by
-
Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs
Journal of Human Genetics (2009)
-
2007: Spotlight on drug safety
Nature Reviews Drug Discovery (2008)
-
Novel diabetes drugs to face higher hurdles?
Nature Reviews Drug Discovery (2007)
